MANX HEALTHCARE SORE THROAT RELIEF

Posology Adults and children 13 years and over:

Administer 2 sprays (3 mg) to the back of the throat. Repeat every two to three hours up to a maximum of 8 doses per day. This product is contraindicated in children 12 years and under. Method of administration: oromucosal Hold breath and spray to the back of the throat.

Do not use in a patient who is unable to hold their breath whilst spraying. Before first use or after prolonged storage press the plunger 2 – 3 times to activate the spray. Do this away from the face, into a sink. 5 mg Oromucosal Spray Pressing the plunger once delivers a single metered spray.

Allergic reactions have been reported very occasionally with benzocaine. There have been occasional reports of temporary breathing difficulty, face or mouth swelling. Methaemoglobinaemia has been reported with benzocaine use. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.

It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store.

Do not administer to children 12 years and under Do not use for more than 3 consecutive days Do not spray into eyes If sore throat is severe or persistent, or accompanied by fever, headache or nausea, consult your doctor. You should experience temporary numbness in your throat after using the spray.

This indicates that the product is working. Avoid eating or drinking as long as the numbness lasts.

Labelling will include the following information:

Do not use if you have difficulty in breathing, noisy breathing or severe difficulty in swallowing. Do not use if you have been told that you have a rare blood condition called methaemoglobinaemia. This medicine contains less than 1 mmol sodium (23 mg) per actuation, that is to say essentially ‘sodium-free’.

1. Methaemoglobinaemia